Need a mesothelioma lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
A study in the Journal of the American Medical Association (JAMA) reveals that women who took hormone replacement therapy (HRT) face an increased risk of cancer several years after stopping the treatment, according to an NPR report.
Overweight women suffer more hot flashes during menopause than women who maintain a normal weight, according to the Hartford Courant. The news story references a study published by the American Journal of Epidemiology that debunks an earlier belief that menopausal women who were heavier experienced fewer hot flashes than thin women.
Two years ago, M.D. Anderson researchers announced a 7 percent drop in breast cancer rates which coincidentally occurred around the same time that women were being told by the media and their doctors of the possible link between hormone replacement therapy (HRT) and serious diseases and conditions such as breast cancer and heart disease.
Strong bones may make older, post-menopausal women at greater risk for breast cancer, according to a study conducted by University of Arizona, reported by KABC-TV in Los Angeles.
Bone scans are used to check for osteoporosis, a disease in which bones become fragile and more likely to break. Women are typically four times more likely than men to suffer from osteoporosis. Because there is a direct relationship between the lack of estrogen after menopause and the development of osteoporosis, most doctors advise older women to have bone density tests every year along with a mammogram.
October is breast cancer awareness month, which makes it a perfect time for women currently taking or considering taking hormone replacement therapy (HRT), to assess their breast health.
Oestrogen and progesterone are necessary hormones for reproduction which are produced naturally by a woman’s ovaries. At around the age of 50 the body slows down and eventually stops production of these hormones, which brings on the menopause or ‘change of life’. The menopause is, strictly speaking, the moment when a woman no longer has menstrual periods, but the term is generally used to describe the years leading up to and after that time.
The Reno trial involving three breast cancer survivors who are suing Wyeth is now nearing the end of its fourth week. The Nevada plaintiffs are suing Wyeth, the manufacturer of Prempro and Premarin, after they each developed breast cancer attributed to their long-term use of combination hormone replacement drugs.
![[ Beasley Allen Law Firm Logo ]](http://www.hrt-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}
